Article Versions Notes

Ribaldone DG, Fagoonee S, Astegiano M, Durazzo M, Morgando A, Sprujevnik T, Giordanino C, Baronio M, De Angelis C, Saracco GM, et al. Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients. Journal of Clinical Medicine. 2019; 8(2):199. https://doi.org/10.3390/jcm8020199

Ribaldone, Davide Giuseppe, Sharmila Fagoonee, Marco Astegiano, Marilena Durazzo, Anna Morgando, Tatiana Sprujevnik, Chiara Giordanino, Monica Baronio, Claudio De Angelis, Giorgio Maria Saracco, and et al. 2019. "Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients" Journal of Clinical Medicine 8, no. 2: 199. https://doi.org/10.3390/jcm8020199

Ribaldone, D. G., Fagoonee, S., Astegiano, M., Durazzo, M., Morgando, A., Sprujevnik, T., Giordanino, C., Baronio, M., De Angelis, C., Saracco, G. M., & Pellicano, R. (2019). Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients. Journal of Clinical Medicine, 8(2), 199. https://doi.org/10.3390/jcm8020199